6.
Challis G
. Exploitation of the Streptomyces coelicolor A3(2) genome sequence for discovery of new natural products and biosynthetic pathways. J Ind Microbiol Biotechnol. 2013; 41(2):219-32.
DOI: 10.1007/s10295-013-1383-2.
View
7.
Sisson G, Goodwin A, Raudonikiene A, Hughes N, Mukhopadhyay A, Berg D
. Enzymes associated with reductive activation and action of nitazoxanide, nitrofurans, and metronidazole in Helicobacter pylori. Antimicrob Agents Chemother. 2002; 46(7):2116-23.
PMC: 127316.
DOI: 10.1128/AAC.46.7.2116-2123.2002.
View
8.
Avila-Blanco M, Rodriguez M, Moreno Duque J, Munoz-Ortega M, Ventura-Juarez J
. Amoebicidal Activity of Essential Oil of Dysphania ambrosioides (L.) Mosyakin & Clemants in an Amoebic Liver Abscess Hamster Model. Evid Based Complement Alternat Med. 2014; 2014:930208.
PMC: 3976796.
DOI: 10.1155/2014/930208.
View
9.
Chen Y, Garcia de Lomana M, Friedrich N, Kirchmair J
. Characterization of the Chemical Space of Known and Readily Obtainable Natural Products. J Chem Inf Model. 2018; 58(8):1518-1532.
DOI: 10.1021/acs.jcim.8b00302.
View
10.
Carrero J, Curay-Herrera V, Chacon-Nino L, Krengel F, Guzman-Gutierrez S, Silva-Miranda M
. Potent Anti-amoebic Effects of Ibogaine, Voacangine and the Root Bark Alkaloid Fraction of Tabernaemontana arborea. Planta Med. 2022; 89(2):148-157.
DOI: 10.1055/a-1809-1157.
View
11.
Rodriguez-Hernandez K, Martinez I, Agredano-Moreno L, Jimenez-Garcia L, Reyes-Chilpa R, Espinoza B
. Coumarins isolated from Calophyllum brasiliense produce ultrastructural alterations and affect in vitro infectivity of Trypanosoma cruzi. Phytomedicine. 2019; 61:152827.
DOI: 10.1016/j.phymed.2019.152827.
View
12.
Butler M, Blaskovich M, Cooper M
. Antibiotics in the clinical pipeline in 2013. J Antibiot (Tokyo). 2013; 66(10):571-91.
DOI: 10.1038/ja.2013.86.
View
13.
Calzada F, Yepez-Mulia L, Aguilar A
. In vitro susceptibility of Entamoeba histolytica and Giardia lamblia to plants used in Mexican traditional medicine for the treatment of gastrointestinal disorders. J Ethnopharmacol. 2006; 108(3):367-70.
DOI: 10.1016/j.jep.2006.05.025.
View
14.
Wright G
. Something old, something new: revisiting natural products in antibiotic drug discovery. Can J Microbiol. 2014; 60(3):147-54.
DOI: 10.1139/cjm-2014-0063.
View
15.
Medina-Franco J, Mendez-Lucio O, Martinez-Mayorga K
. The interplay between molecular modeling and chemoinformatics to characterize protein-ligand and protein-protein interactions landscapes for drug discovery. Adv Protein Chem Struct Biol. 2014; 96:1-37.
DOI: 10.1016/bs.apcsb.2014.06.001.
View
16.
Kutsch O, Levy D, Bates P, Decker J, Kosloff B, Shaw G
. Bis-anthracycline antibiotics inhibit human immunodeficiency virus type 1 transcription. Antimicrob Agents Chemother. 2004; 48(5):1652-63.
PMC: 400550.
DOI: 10.1128/AAC.48.5.1652-1663.2004.
View
17.
Piel J
. Approaches to capturing and designing biologically active small molecules produced by uncultured microbes. Annu Rev Microbiol. 2011; 65:431-53.
DOI: 10.1146/annurev-micro-090110-102805.
View
18.
Newman D, Cragg G
. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J Nat Prod. 2020; 83(3):770-803.
DOI: 10.1021/acs.jnatprod.9b01285.
View
19.
Seifert K, Duchene M, Wernsdorfer W, Kollaritsch H, Scheiner O, WIEDERMANN G
. Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica. Antimicrob Agents Chemother. 2001; 45(5):1505-10.
PMC: 90496.
DOI: 10.1128/AAC.45.5.1505-1510.2001.
View
20.
Aguilar-Diaz H, Carrero J, Arguello-Garcia R, Laclette J, Morales-Montor J
. Cyst and encystment in protozoan parasites: optimal targets for new life-cycle interrupting strategies?. Trends Parasitol. 2011; 27(10):450-8.
DOI: 10.1016/j.pt.2011.06.003.
View